These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 16048554)

  • 1. Experimental models of inflammatory bowel disease reveal innate, adaptive, and regulatory mechanisms of host dialogue with the microbiota.
    Elson CO; Cong Y; McCracken VJ; Dimmitt RA; Lorenz RG; Weaver CT
    Immunol Rev; 2005 Aug; 206():260-76. PubMed ID: 16048554
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Commensal bacteria (normal microflora), mucosal immunity and chronic inflammatory and autoimmune diseases.
    Tlaskalová-Hogenová H; Stepánková R; Hudcovic T; Tucková L; Cukrowska B; Lodinová-Zádníková R; Kozáková H; Rossmann P; Bártová J; Sokol D; Funda DP; Borovská D; Reháková Z; Sinkora J; Hofman J; Drastich P; Kokesová A
    Immunol Lett; 2004 May; 93(2-3):97-108. PubMed ID: 15158604
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Involvement of innate immunity in the development of inflammatory and autoimmune diseases.
    Tlaskalová-Hogenová H; Tucková L; Stepánková R; Hudcovic T; Palová-Jelínková L; Kozáková H; Rossmann P; Sanchez D; Cinová J; Hrncír T; Kverka M; Frolová L; Uhlig H; Powrie F; Bland P
    Ann N Y Acad Sci; 2005 Jun; 1051():787-98. PubMed ID: 16127016
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gut microbiota: mining for therapeutic potential.
    O'Hara AM; Shanahan F
    Clin Gastroenterol Hepatol; 2007 Mar; 5(3):274-84. PubMed ID: 17368226
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular interactions between bacteria, the epithelium, and the mucosal immune system in the intestinal tract: implications for chronic inflammation.
    Clavel T; Haller D
    Curr Issues Intest Microbiol; 2007 Sep; 8(2):25-43. PubMed ID: 17542334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetic and spontaneous models of inflammatory bowel disease in rodents: evidence for abnormalities in mucosal immune regulation.
    Powrie F; Leach MW
    Ther Immunol; 1995 Apr; 2(2):115-23. PubMed ID: 8729882
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mouse models of inflammatory bowel disease.
    Wirtz S; Neurath MF
    Adv Drug Deliv Rev; 2007 Sep; 59(11):1073-83. PubMed ID: 17825455
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Animal models of inflammatory bowel disease: lessons from enteric infections.
    Eckmann L
    Ann N Y Acad Sci; 2006 Aug; 1072():28-38. PubMed ID: 17057188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of the innate immune system in the pathogenesis of inflammatory bowel disease.
    van Lierop PP; Samsom JN; Escher JC; Nieuwenhuis EE
    J Pediatr Gastroenterol Nutr; 2009 Feb; 48(2):142-51. PubMed ID: 19179875
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unravelling the pathogenesis of inflammatory bowel disease.
    Xavier RJ; Podolsky DK
    Nature; 2007 Jul; 448(7152):427-34. PubMed ID: 17653185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mouse models of intestinal inflammation as tools to understand the pathogenesis of inflammatory bowel disease.
    Uhlig HH; Powrie F
    Eur J Immunol; 2009 Aug; 39(8):2021-6. PubMed ID: 19672896
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commensal-innate immune miscommunication in IBD pathogenesis.
    Cario E
    Dig Dis; 2012; 30(4):334-40. PubMed ID: 22796793
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune regulation in the intestine: a balancing act between effector and regulatory T cell responses.
    Powrie F
    Ann N Y Acad Sci; 2004 Dec; 1029():132-41. PubMed ID: 15681752
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microbial influences in inflammatory bowel diseases.
    Sartor RB
    Gastroenterology; 2008 Feb; 134(2):577-94. PubMed ID: 18242222
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental influences on T regulatory cells in inflammatory bowel disease.
    Hardenberg G; Steiner TS; Levings MK
    Semin Immunol; 2011 Apr; 23(2):130-8. PubMed ID: 21295492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aetiology of inflammatory bowel disease (IBD): role of intestinal microbiota and gut-associated lymphoid tissue immune response.
    Thompson-Chagoyán OC; Maldonado J; Gil A
    Clin Nutr; 2005 Jun; 24(3):339-52. PubMed ID: 15896420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Innate immunity in inflammatory bowel disease: state of the art.
    Hisamatsu T; Ogata H; Hibi T
    Curr Opin Gastroenterol; 2008 Jul; 24(4):448-54. PubMed ID: 18622158
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular approaches to the role of the microbiota in inflammatory bowel disease.
    Elson CO; Cong Y; Qi F; Hershberg RM; Targan SR
    Ann N Y Acad Sci; 2006 Aug; 1072():39-51. PubMed ID: 17057189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epithelial NEMO links innate immunity to chronic intestinal inflammation.
    Nenci A; Becker C; Wullaert A; Gareus R; van Loo G; Danese S; Huth M; Nikolaev A; Neufert C; Madison B; Gumucio D; Neurath MF; Pasparakis M
    Nature; 2007 Mar; 446(7135):557-61. PubMed ID: 17361131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homeostatic (IL-7) and effector (IL-17) cytokines as distinct but complementary target for an optimal therapeutic strategy in inflammatory bowel disease.
    Kanai T; Nemoto Y; Kamada N; Totsuka T; Hisamatsu T; Watanabe M; Hibi T
    Curr Opin Gastroenterol; 2009 Jul; 25(4):306-13. PubMed ID: 19448533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.